ArticleFrontiers in oncology2023

Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China.

Wenyu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.